Brief: Gentian Diagnostics Q2 EBITDA At NOK 3.6 Million
24/08/2023 07:15
Aug 24 (Reuters) - Gentian Diagnostics ASA GENT.OL :
* RECORD SALES OF MNOK 34.2 IN 2Q23, UP 13% VERSUS 2Q22
* Q2 EBITDA NOK 3.6 MILLION
Source text for Eikon: ID:nObijMHVla
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company